cancer treatment

The Mediterranean diet reduces by 6% the risk of developing breast cancer

February 14, 2013 03:57 PM | CNA / Elise Griset

Researchers from the Catalan Institute of Oncology have led the largest international study on breast cance4r and nutrition. The 8-year study has been based on 335,062 women between 35 and 70 years old. It has involved 23 centres in 10 European countries and it has been published in the ‘International Journal of Cancer’. The study concludes that the Mediterranean diet can reduce the risk of breast cancer by 6% among women in general and 7% in the case of post-menopausal patients.

Time spent between the first and the second chemotherapy treatment increases survival rate in bladder cancer

January 23, 2013 06:17 PM | CNA / Rosa Soto

A research group led by Catalan doctor Joaquim Bellmunt at the Hospital del Mar has shown in a study how important the time between two chemotherapy treatments is in increasing the curing rates of bladder cancer. The study was published by the journal ‘European Urology’ and has encouraged the researchers to develop new drugs for treating this type of tumour.

The key process behind the metastasis of colon cancer is discovered by Catalan scientists

November 12, 2012 11:25 PM | CNA

Scientists from the Colorectal Cancer Laboratory at the Barcelona Institute of Biomedical Research (IRB) have discovered the essential process that allows colon cancer cells to metastasise. They have concluded that tumour cells need to form alliances with healthy cells in order to be able to colonise other organs. Tumour cells can survive in the transition period during the metastasis process thanks to a protein (interleukin-11), which is produced by healthy cells that are exposed to another protein (TGF-beta) present in the tumour’s microenvironment. This discovery may lead to new treatments and diagnostic proceedings for colon cancer patients. A test to predict relapse cases and target treatments is likely to be ready in 5 years. The study has been published by the prestigious journal Cancer Cell.

Memorial Sloan-Kettering Cancer Center appoints the Catalan Josep Baselga as its new Physician-in-Chief

September 5, 2012 11:30 PM | CNA

The New York-based centre is considered the world’s best hospital in the fight against cancer. Dr. Baselga will direct a team of 834 doctors attending more than 123,000 patients per year. The Catalan doctor is currently Chief of the Division of Hematology/Oncology at Massachusetts General Hospital (MGH), Associate Director of the MGH Cancer Center, and Scientific Director of the Vall d’Hebron Institute of Oncology (VHIO) in Barcelona. Furthermore, Dr. Baselga holds a Chair of Medicine at the Universitat Autònoma de Barcelona (UAB). The Catalan doctor will combine his new job in New York, which will start on January 1st, with his position in Barcelona’s centre.

Budget reduction puts Catalan healthcare in the spotlight

October 4, 2011 03:23 PM | CNA

The Catalan Government is obliged to reduce the public deficit and the public healthcare system is also subsequently affected by the budget cuts. Doctor and nursing unions are mobilised, while salary reduction and temporary lay offs are being discussed. Waiting lists have increased due to some hospital services being partially and temporarily closed, especially during the summer months. Many citizens have been protesting, in different demonstrations. The Catalan Health Ministry announced new maximum waiting times for severe interventions. In addition, some hospitals are reopening some operating rooms.